PDCD1 and neoplasm: Moreover, our findings indicate that the metastatic HGSOC microenvironment, and notably its enrichment for TLSs, may offer a preferential platform to identify patients who after NACT and surgical tumor removal may benefit from ICIs targeting PD1.